---
title: "Star Health & Allied Insurance Company Ltd (STARHEALTH) — Share Price, Financials & Analysis"
symbol: "STARHEALTH"
company: "Star Health & Allied Insurance Company Ltd"
canonical: "https://tapetide.com/stocks/STARHEALTH"
isin: "INE575P01011"
nse_symbol: "STARHEALTH"
bse_code: "543412"
sector: "Financial Services"
industry: "Insurance"
market_cap_cr: 33920.25
generated_at: "2026-09-13T19:26:40.963Z"
---

# Star Health & Allied Insurance Company Ltd (STARHEALTH)

Canonical page: https://tapetide.com/stocks/STARHEALTH

## Company

- **NSE Symbol:** STARHEALTH
- **BSE Code:** 543412
- **ISIN:** INE575P01011
- **Sector:** Financial Services
- **Industry:** Insurance
- **Macro Sector:** Financial Services
- **Stock Type:** EQUITY
- **Listed Since:** 2021-12-10
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** starhealth.in

## About

Star Health & Allied Insurance Ltd (Star)  is  India’s first Standalone Health Insurance provider and is the largest private health insurer in India with a market share of 15.8% in the Indian health insurance market in FY21 with leadership in the attractive retail health segment.[1]

## Latest Price

- **Price:** ₹562.7
- **Change:** -13.55 (-2.35%)
- **Open:** ₹575
- **Day High:** ₹579.75
- **Day Low:** ₹559.7
- **Previous Close:** ₹576.25
- **Volume:** 460832
- **As Of:** 2026-09-11T10:21:55+00:00

## Key Fundamentals

Observed at 2026-09-11T04:35:51.330596Z.

- **Market Cap:** ₹33920.25 Cr
- **Classification:** Smallcap
- **P/E (reported):** 40.1
- **P/E (TTM):** 39.24
- **EPS (TTM):** ₹14.34
- **EPS (reported):** ₹14.96
- **Book Value:** ₹128.94
- **Price to Book:** 4.46
- **Dividend Yield:** 0%
- **ROE:** 7.35%
- **ROCE:** -9.4%
- **Debt to Equity:** 0.06
- **Revenue (yearly):** ₹17834.4 Cr
- **Net Income:** ₹557 Cr
- **EBITDA:** ₹833.6 Cr
- **52-Week High:** ₹624.9
- **52-Week Low:** ₹416.55
- **RSI (14):** 51.47

## Tapetide Score

- **Score:** 47 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Rising
- **Percentile:** 35.6 (of 4473 scored stocks)
- **Confidence:** 97%
- **Data coverage:** 94%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 32.68 | 9% |
| growth | 40.63 | 9% |
| momentum | 75.58 | 12% |
| ownership | 48.78 | 24% |
| quality | 46.83 | 22% |
| valuation | 39.49 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.

### Weaknesses

- Stock is trading at 4.37 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 10.2% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 35.89% | 43.02% | — |
| ebitda margin growth | 390.54% | -19.34% | -44.86% | -136.6% |
| net income growth | 393.89% | -13.76% | -3% | 20% |
| revenue growth | 18.55% | 10.68% | 14% | 29% |
| roce | — | -38.64% | -67.21% | -5.65% |
| roe | — | -19.67% | 9.72% | -145.09% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 3461 | 3578 | 3688 | 3816 | 4058 | 4146 | 4081 | 4880 | 4378 | 4566 | 4648 | 5522 |
| Expenses | 3296 | 3191 | 3502 | 3391 | 3912 | 3861 | 4089 | 4292 | 4303 | 4395 | 4500 | 4773 |
| Operating Profit | 165 | 387 | 186 | 425 | 147 | 285 | -7 | 588 | 75 | 172 | 148 | 749 |
| OPM % | 4.8 | 11 | 5 | 11 | 3.6 | 7 | -0.2 | 12 | 1.7 | 3.8 | 3.2 | 14 |
| Other Income | 2 | 1 | 3 | 1 | 2 | 2 | 6 | 0 | 3 | 2 | 4 | -8 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 167 | 388 | 190 | 426 | 149 | 287 | -1 | 588 | 78 | 173 | 151 | 742 |
| Tax % | 25 | 25 | 25 | 25 | 25 | 25 | -159 | 25 | 29 | 26 | 26 | 26 |
| Net Profit | 125 | 290 | 142 | 319 | 111 | 215 | 1 | 438 | 55 | 128 | 111 | 550 |
| EPS in Rs | 2.15 | 4.95 | 2.43 | 5.45 | 1.89 | 3.66 | 0.01 | 7.45 | 0.93 | 2.18 | 1.89 | 9.34 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 2888 | 3775 | 4987 | 5050 | 10602 | 12096 | 14021 | 16101 | 17825 | 19114 |
| Expenses | 2673 | 3565 | 4544 | 6447 | 11962 | 11223 | 12840 | 15180 | 17001 | 17971 |
| Operating Profit | 215 | 210 | 443 | -1397 | -1360 | 873 | 1182 | 921 | 824 | 1143 |
| OPM % | 7 | 6 | 9 | -28 | -13 | 7 | 8 | 6 | 4.6 | 6 |
| Other Income | 0 | 0 | 0 | -3 | 7 | 5 | 6 | 12 | 9 | 1 |
| Interest | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 23 | 28 | 29 | 46 | 43 | 52 | 59 | 71 | 79 | 0 |
| Profit before tax | 171 | 182 | 413 | -1446 | -1397 | 826 | 1129 | 861 | 754 | 1144 |
| Tax % | 1 | 30 | 35 | -25 | -25 | 25 | 25 | 25 | 26 | — |
| Net Profit | 170 | 128 | 268 | -1086 | -1041 | 619 | 845 | 646 | 557 | 844 |
| EPS in Rs | 3.73 | 2.81 | 5.46 | -19.81 | -18.08 | 10.63 | 14.44 | 10.99 | 9.47 | 14.34 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 456 | 456 | 456 | 491 | 548 | 576 | 582 | 585 | 588 | 588 |
| Reserves | 334 | 504 | 773 | 1153 | 2947 | 4045 | 4862 | 5799 | 6471 | 6987 |
| Borrowings | 0 | 250 | 250 | 250 | 250 | 720 | 470 | 470 | 470 | 470 |
| Other Liabilities | 1423 | 2138 | 3394 | 4233 | 6756 | 8174 | 9313 | 10914 | 13255 | 16019 |
| Total Liabilities | 2213 | 3347 | 4872 | 6127 | 10501 | 13514 | 15226 | 17768 | 20785 | 24064 |
| Fixed Assets | 77 | 92 | 85 | 90 | 183 | 113 | 217 | 159 | 357 | 404 |
| CWIP | 7 | 5 | 13 | 12 | 19 | 4 | 10 | 16 | 24 | 9 |
| Investments | 1428 | 2165 | 3030 | 4290 | 6733 | 11373 | 13276 | 15491 | 17703 | 19780 |
| Other Assets | 700 | 1085 | 1744 | 1735 | 3565 | 2024 | 1723 | 2102 | 2701 | 3871 |
| Total Assets | 2213 | 3347 | 4872 | 6127 | 10501 | 13514 | 15226 | 17768 | 20785 | 24064 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 321 | 557 | 776 | 647 | 890 | 56 | 1276 | 1310 | 1379 | 1873 |
| Cash from Investing Activity | -497 | -663 | -731 | -1006 | -2418 | -3786 | -1097 | -1177 | -1151 | -1067 |
| Cash from Financing Activity | 310 | 249 | 333 | 122 | 2613 | 2509 | -268 | 23 | -4 | -31 |
| Net Cash Flow | 134 | 143 | 379 | -237 | 1086 | -1221 | -89 | 156 | 224 | 775 |
| Free Cash Flow | 283 | 521 | 746 | 614 | 844 | -7 | 1229 | 1187 | 1297 | 1797 |
| CFO/OP | 228 | 260 | 397 | 168 | -70 | -4 | 145 | 119 | 170 | 250 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital Days | -191 | -196 | -260 | -238 | -397 | -258 | -255 | -249 | -261 | -286 |
| ROCE % | 21 | 19 | 14 | 25 | -51 | -31 | 15 | 18 | 12 | 10 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 58.02% | 57.94% | 57.92% | 57.9% | 57.69% | 57.68% | 57.67% | 58.04% | 58.02% | 57.98% | 57.98% | 58.01% |
| FIIs | 16.89% | 16.39% | 26.57% | 21.58% | 17.65% | 17.51% | 18.68% | 13.9% | 13.5% | 14.07% | 15.05% | 16.04% |
| DIIs | 5.28% | 5.61% | 11.15% | 15.11% | 17.05% | 16.49% | 15.43% | 21.09% | 21.09% | 20.96% | 20.31% | 19.41% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 3.27% | 3.16% | 2.79% | 3.55% | 5.21% | 5.89% | 5.57% | 4.42% | 4.78% | 4.38% | 4.2% | 4.14% |
| Others | 16.55% | 16.91% | 1.57% | 1.85% | 2.4% | 2.43% | 2.64% | 2.56% | 2.6% | 2.61% | 2.47% | 2.39% |
| No. of Shareholders | 171423 | 183343 | 175298 | 189347 | 196778 | 217516 | 221612 | 203563 | 202938 | 186448 | 179067 | 168763 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 4 / 7 / 8

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 565.67 | Sell |
| EMA (10) | 568.97 | Sell |
| SMA (20) | 573.05 | Sell |
| EMA (20) | 572.09 | Sell |
| SMA (50) | 582.39 | Sell |
| EMA (50) | 571.81 | Sell |
| SMA (100) | 558.06 | Buy |
| EMA (100) | 554.94 | Buy |
| SMA (200) | 510.38 | Buy |
| EMA (200) | 522.61 | Buy |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 42.46 | Neutral |
| MACD (12,26,9) | -3.82 | Sell |
| Stochastic (14,3,3) | 56.88 | Neutral |
| ADX (14) | 17.38 | Neutral |
| Williams %R (14) | -61.63 | Neutral |
| ATR (14) | 15.63 | Neutral |
| ROC (12) | -3.61 | Sell |
| Stoch RSI (14) | 36.71 | Neutral |
| UO (7,14,28) | 51.55 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 15 | 75% |
| Hold | 3 | 15% |
| Sell | 2 | 10% |

Based on 20 analyst ratings, observed at 2026-09-11T04:35:51.132088+00:00.

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9h - Star Health and Allied Insurance Company Limited has informed about the Schedule of Earnings Call dated April 29, 2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 9h - Star Health and Allied Insurance Company Limited has informed about the Schedule of Earnings Call dated April 29, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/94112cb7-430f-49be-8b57-0c158e8171e2.pdf) |
| 8h - Star Health filed audited Q4/FY26 results; auditors issued unmodified opinion, board approved April 28, 2026. | [Audited Financial Results For The Quarter And Financial Year Ended March 31, 2026 8h - Star Health filed audited Q4/FY26 results; auditors issued unmodified opinion, board approved April 28, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/1de2e437-833f-4671-b0a4-5bd0a70571ca.pdf) |
| 8h - Board approved audited standalone results for FY2026; auditors issued unmodified opinion. | [Board Meeting Outcome for Outcome Of The Board Meeting For Declaration Of Standalone Financial Results For Quarter And Financial Year Ended March 31, 2026 8h - Board approved audited standalone results for FY2026; auditors issued unmodified opinion.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/0b48af09-b012-4349-8fbc-000905cdde61.pdf) |
| 7h - FY26 PAT rose 16% to ₹911 crore; GWP up 16% to ₹20,369 crore, combined ratio improved. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 7h - FY26 PAT rose 16% to ₹911 crore; GWP up 16% to ₹20,369 crore, combined ratio improved.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/1fb914ee-4657-4a54-9b3d-c52b66708de3.pdf) |
| 7h - Board approved amended Insider Trading Policy on April 28, 2026. | [Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015 7h - Board approved amended Insider Trading Policy on April 28, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/ff8322d1-b7e0-487e-b060-c6f0cb496e31.pdf) |
| 6 Mar - Star Health and Allied Insurance Company Limited has informed regarding Schedule of meet with single Analyst/Investor dated March 11, 2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 6 Mar - Star Health and Allied Insurance Company Limited has informed regarding Schedule of meet with single Analyst/Investor dated March 11, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a61331c0-85af-417a-92d6-6dadcdefecd9.pdf) |
| 6 Mar - Analyst/institutional investor meeting on March 11, 2026 with Sumitomo Mitsui DS Asset Management; presentation link provided. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 6 Mar - Analyst/institutional investor meeting on March 11, 2026 with Sumitomo Mitsui DS Asset Management; presentation link provided.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d29c361a-f9f1-468f-9b8a-2853c7a467b7.pdf) |
| 6 Apr - IRDAI approved transmission of 8,28,82,958 shares held by late Rakesh Jhunjhunwala on April 6, 2026. | [Announcement Under SEBI (LODR) Regulations, 2015 6 Apr - IRDAI approved transmission of 8,28,82,958 shares held by late Rakesh Jhunjhunwala on April 6, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a7e7957f-9c3b-4977-88f1-f6d2b5b607f6.pdf) |
| 5 May - Star Health and Allied Insurance Company Limited has informed regarding transcripts of the Earnings Call dated April 29, 2026. | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript 5 May - Star Health and Allied Insurance Company Limited has informed regarding transcripts of the Earnings Call dated April 29, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/7fabbfcb-e043-4106-8755-7ca21271d877.pdf) |
| 4 May - Star Health and Allied Insurance Company Limited intimated Schedule of Analyst/Investor meet dated May 07, 2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 4 May - Star Health and Allied Insurance Company Limited intimated Schedule of Analyst/Investor meet dated May 07, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c1823230-f89b-4473-b52b-f3cf27098ed9.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-29 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11b748ef-7dc7-41d8-a128-e7c88fdfb331.pdf) |
| 2026-08-29 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7adaea7-4320-4695-bf85-6a038d686571.pdf) |
| 2026-08-28 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c5f3fc93-54b2-42cd-a371-f3599a7181a4.pdf) |
| 2026-08-28 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62dad26a-f082-447e-8a7b-f6528ecb94b7.pdf) |
| 2026-08-28 | [Announcement under Regulation 30 (LODR)-Change in Directorate](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1aeb0ffc-12cd-4506-8bac-7348619aa11d.pdf) |
| 2026-08-27 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff32ff91-de9e-468d-b446-e557e10ee11a.pdf) |
| 2026-08-26 | [Disclosure Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27288a59-aa5c-4a9a-bf5a-857eefaaa85b.pdf) |
| 2026-08-14 | [Disclosure Under Regulation 31A(8)(C) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da27d7b4-a254-4b3e-bc6c-59f38e4300c7.pdf) |
| 2026-08-13 | [Disclosure Under Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4fcf7b76-af4d-4191-90c3-8494e293e50b.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=583214dc-73c9-4f61-976a-5bdccc20d988.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-05 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93f3edf2-74e5-48b0-8caf-9a1acff4a3bc.pdf) |
| 2026-05-05 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7fabbfcb-e043-4106-8755-7ca21271d877.pdf) |
| 2026-02-03 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=978fc436-4f51-4c3f-ad59-29e601ee8170.pdf) |
| 2025-11-03 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c98629a0-8226-4b8b-ae5c-846f00a495d5.pdf) |
| 2025-08-05 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f12dbb0-bdf6-49c1-9940-d20a8a3c0d23.pdf) |
| 2025-05-07 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dfefb0b6-169f-48ad-9757-2adb18f1b2d2.pdf) |
| 2025-01-31 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0fd3bbbf-c88d-41f5-a9b5-14824726fd7b.pdf) |
| 2024-11-04 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4fca3132-9596-40ae-8ba5-fe34e4add756.pdf) |
| 2024-08-05 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dea28c25-758b-4691-b4f1-fab7d1b2707a.pdf) |
| 2024-05-04 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8323e6b6-9925-4132-b219-b85cb280e1f1.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-07-30 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98478999-93b7-4077-aacb-e7ed72aa7f7b.pdf) |
| 2026-04-29 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8b5bc97-dc8f-4552-9ffe-374147eb4064.pdf) |
| 2026-01-29 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77190c93-c4d3-44e8-a223-d109b6c9257c.pdf) |
| 2025-10-29 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aed3ccad-ba91-4668-b764-f721ef6e2ef4.pdf) |
| 2025-01-29 | [Earnings Call Audio Recording - Q3 & 9M - FY2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10016b54-21a9-4e54-b90f-521a0d863cf4.pdf) |
| 2024-10-30 | [Earnings Call Audio Recording - Q2 & H1 - FY2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=612f57db-12f3-4fa9-8b79-d787c6ea6a19.pdf) |
| 2024-07-31 | [Earnings Call Audio Recording - Q1 - FY2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1083f0e6-0a55-4316-8d13-40041ba91b24.pdf) |
| 2024-05-02 | [Earning Call Audio Recording - April 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=697cb60f-9a77-49c6-9450-b24288c41ecd.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-29 | [Standalone Unaudited Limited Reviewed Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05ac4c95-b8ae-480e-9ac1-1e6ae6b12472.pdf) |
| 2026-04-28 | [Audited Financial Results For The Quarter And Financial Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1de2e437-833f-4671-b0a4-5bd0a70571ca.pdf) |
| 2025-04-29 | [Declaration Of Audited Financial Results Of The Quarter And Year Ended 31 March 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3ea495f-c00d-44df-bbe5-35db8ecff437.pdf) |
| 2025-01-28 | [Unaudited Financial Results -December 312024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38b751f3-1e7e-412c-9680-a3b80d0fcb27.pdf) |
| 2024-04-30 | [Star Health And Allied Insurance Company Limited Has Informed The Exchange Regarding Outcome Of Board Meeting Held On April 30, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a3d8f92-5877-48f8-ba79-ac85587d090f.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-07-29 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08aadb82-4eee-4d94-b2c8-71bfa7283828.pdf) |
| 2026-04-29 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8114df0-5800-4af2-a11c-24d183ab709f.pdf) |
| 2026-01-29 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9bebde68-155d-4d31-a3c8-69d24f72cf07.pdf) |
| 2026-01-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5344a57-d757-436f-9a28-fd0695f95776.pdf) |
| 2025-10-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a2d8b9d-02b0-4a8e-a0a0-a75b54aca2c3.pdf) |
| 2025-07-29 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc3cee2b-1e53-4967-96e6-ff4562b0d025.pdf) |
| 2025-04-30 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb975812-de4a-4a89-968b-56a0cc6e5328.pdf) |
| 2025-04-29 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9e188cd-b794-48e5-997a-bc23c5d64642.pdf) |
| 2025-01-30 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=920f8ca5-c3c3-446a-8a8a-4fc4cb939566.pdf) |
| 2025-01-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b617dad-3f86-49c8-bd56-fd50ade91833.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f0ea254d-1d83-4d79-ba2a-25c61da6e170.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c98629a0-8226-4b8b-ae5c-846f00a495d5.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4fca3132-9596-40ae-8ba5-fe34e4add756.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7fabbfcb-e043-4106-8755-7ca21271d877.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dfefb0b6-169f-48ad-9757-2adb18f1b2d2.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8323e6b6-9925-4132-b219-b85cb280e1f1.pdf) |
| Jun 2024 | [Concall - Jun 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f78e6319-c44d-4026-a63d-373aeab5fe4c.pdf) |
| Jun 2024 | [Concall - Jun 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f78e6319-c44d-4026-a63d-373aeab5fe4c.pdf) |
| Jan 2025 | [Concall - Jan 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8b617dad-3f86-49c8-bd56-fd50ade91833.pdf) |
| Jan 2025 | [Concall - Jan 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0fd3bbbf-c88d-41f5-a9b5-14824726fd7b.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a77c54f6-d67e-4e62-8aba-baeb8ebf1dce.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cd3a9149-106d-4824-ae26-3adcdd4ba707.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:26:40.963Z.